[HTML][HTML] New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

O Heisel, R Heisel, R Balshaw, P Keown - American Journal of …, 2004 - Elsevier
New onset diabetes mellitus (NODM) is a serious complication of transplantation. This meta-
analysis evaluates the reported incidence of NODM after solid organ transplantation in …

Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk

JMM Boots, MHL Christiaans, JP van Hooff - Drugs, 2004 - Springer
In the control of acute rejection, attention is being focused more and more on the long-term
adverse effects of the immunosuppressive agents used. Since cardiovascular disease is the …

[HTML][HTML] Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally

APJ De Vries, SJL Bakker, WJ Van Son… - American Journal of …, 2004 - Elsevier
Chronic renal transplant dysfunction (CRTD) remains a leading cause of renal allograft loss.
Evidence suggests that immunological and ischemic insults are mainly associated with …

Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis

CC Murphy, K Greiner, J Plskova… - Archives of …, 2005 - jamanetwork.com
Objectives To compare the efficacy and tolerability of tacrolimus and cyclosporine therapy
for noninfectious posterior segment intraocular inflammation and to evaluate their effect on …

Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results

BK Krämer, G Montagnino, D Del Castillo… - Nephrology Dialysis …, 2005 - academic.oup.com
Background. Comparison studies of calcineurin inhibitors as cornerstone
immunosuppressants in renal transplantation have demonstrated that tacrolimus …

[HTML][HTML] Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile

MA Artz, JMM Boots, G Ligtenberg, JI Roodnat… - American Journal of …, 2004 - Elsevier
Long-term use of cyclosporine after renal transplantation results in nephrotoxicity and an
increased cardiovascular risk profile. Tacrolimus may be more favorable in this respect. In …

Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus

MA Artz, JMM Boots, G Ligtenberg… - Journal of the …, 2003 - journals.lww.com
Cyclosporine is considered to contribute to the high cardiovascular morbidity and mortality in
patients after renal transplantation. Tacrolimus may be more favorable in this respect, but …

[HTML][HTML] Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus …

KM Wissing, D Abramowicz, L Weekers… - American Journal of …, 2018 - Elsevier
Tacrolimus (TAC) increases the risk of posttransplant diabetes (PTDM) compared with
cyclosporine A (CYC). The present 12-month, multicenter, investigator-driven, prospective …

Evaluating mechanisms of post-transplant diabetes mellitus

JP Van Hooff, MHL Christiaans… - Nephrology Dialysis …, 2004 - academic.oup.com
Post-transplant diabetes mellitus (PTDM) is a frequent complication in renal transplantation.
While both tacrolimus and ciclosporin are known to be associated with PTDM, the …

Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects

IHHT Klein, A Abrahams, T van Ede, RJ Hené… - …, 2002 - journals.lww.com
Background. The side effects of cyclosporine, nephrotoxicity and hypertension, contribute to
long-term renal graft failure and cardiovascular morbidity in graft recipients. It is not clear …